Clinical Trials on Late-life Depression in Russian Federation

Total 122 results

Federal Research Center of Fundamental and Translational...

Completed

Real-time fMRI Neurofeedback for Mild/Moderate Depression

Depression Moderate | Depression Mild

Russian Federation
Russian Academy of Medical Sciences
Russian Science Foundation

Completed

Efficacy of Resveratrol in Depression

Depression

Russian Federation
Servier Russia

Recruiting

Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR) (TELESPHOR)

Depression | COVID-19

Russian Federation
Kalaco Scientific, Inc.

Completed

Nexalin Therapy for the Treatment of Depressive Symptoms

Depression

Russian Federation
AstraZeneca

Completed

Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression

Schizophrenia | Schizoaffective Disorder | Recurrent Depression

Russian Federation
Bakulev Scientific Center of Cardiovascular Surgery
Astrakhan Federal Centre For Cardiac Surgery; State Budget Public Health Institution...

Recruiting

Auricular Vagus Stimulation and Heart Rate Variability

Heart Rate Variability | Vagus Nerve Stimulation

Russian Federation
I.M. Sechenov First Moscow State Medical University

Active, not recruiting

Quality of Life, Functional Outcomes and Costs in Shoulder Arthroplasty

Shoulder Arthropathy

Russian Federation
ITMO University

Completed

Health and Quality of Life of ITMO University's Students, Faculty and Staff

Quality of Life

Russian Federation
I.M. Sechenov First Moscow State Medical University

Active, not recruiting

Quality of Life, Functional Outcomes and Costs in Hip Arthroplasty

Hip Arthropathy

Russian Federation
I.M. Sechenov First Moscow State Medical University

Active, not recruiting

Quality of Life, Functional Outcomes and Costs in Knee Arthroplasty

Knee Arthropathy

Russian Federation
Sanofi

Completed

An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients (FIDELIO)

Major Depressive Disorder

Romania, Russian Federation, Ukraine, Mexico, Slovakia, Chile, South Africa
Eli Lilly and Company

Completed

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Bipolar Depression

Russian Federation, United States
H. Lundbeck A/S

Completed

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Major Depressive Disorder

Austria, Russian Federation
Oslo University Hospital
St. Petersburg State Pavlov Medical University

Completed

Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life (NASQ)

Effect of Individualized Nutrition on Quality of Life

Norway, Russian Federation
Federal State Budgetary Organization, Federal Center...
Chuvash State University named after I.N. Ulyanov

Completed

Rational-emotional Behavioral Therapy (REBT) in Patients With Osteoarthritis and Concomitant Diseases Before Arthroplasty (REBT)

Pain | Depression, Anxiety

Russian Federation
Sanofi

Completed

An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder (LENA)

Depressive Disorder

Canada, Russian Federation, Bulgaria, Mexico, Argentina, Chile, Croatia
Moscow Research Institute of Psychiatry
Abbott

Completed

Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine

Recurrent Depressive Disorder

Russian Federation
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.

Depressive Disorder, Major

Russian Federation, Estonia
Sanofi

Completed

An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder

Depressive Disorder

United States, France, Russian Federation, Sweden, Turkey, Czech Republic, Mexico, Croatia
Sanofi

Completed

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder (CALYPSO)

Depressive Disorder | Major Depression

France, Poland, Romania, Russian Federation, Bulgaria, Serbia, Slovakia, Czech Republic, Mexico, Argentina, Croatia, Finland, South Africa
GlaxoSmithKline

Terminated

A Study of GW856553X For the Treatment of Depression

Depressive Disorder, Major

India, Russian Federation, Estonia
Sumitomo Pharma Co., Ltd.

Completed

A Phase III Study of SM-13496 in Patients With Bipolar I Depression.

Bipolar Depression

Lithuania, Malaysia, Russian Federation, Slovakia, Ukraine, Japan, Philippines, Taiwan
ITMO University

Completed

Anxiety Associated With the Use of the Electrocardiogram Function in Smart Watches

Depression | Anxiety Disorders | Mental Health Wellness 1

Russian Federation
State Scientific Centre of Coloproctology, Russian...

Completed

Quality of Life After Transanal Endoscopic Microsurgery (TEM) (QoLTEM)

Transanal Endoscopic Microsurgery (TEM)

Russian Federation
GlaxoSmithKline

Completed

Safety and Efficacy Study in Patients With Major Depressive Disorder

Depressive Disorder

Russian Federation
Sanofi

Completed

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

Major Depressive Disorders

Russian Federation, Spain, Singapore, Taiwan, Tunisia, Argentina, Chile, Hong Kong, Morocco, South Africa, Greece
Penza State University

Recruiting

Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI (CONTRAST-2)

Quality of Life | Arterial Stiffness | Myocardial Infarction, Acute | Myocardial Strain

Russian Federation
I.M. Sechenov First Moscow State Medical University
MEDSI Clinical Hospital 1, ICU

Completed

Rehabilitation Treatment of Patients With COVID-19 (COVID-REHAB)

COVID-19 | Quality of Life | Pneumonia, Viral | Rehabilitation

Russian Federation
Kazan State Medical University
Interregional Clinical Diagnostic Center, Russia

Completed

Quality of Life Questionnaire and Disease Severity Scale

Pelvic Congestion Syndrome

Russian Federation
The League of Clinical Research, Russia

Completed

Health Related Quality of Life of Youth and Young Adults With Haemophilia A (RELOQ)

Hemophilia A

Russian Federation
Sanofi

Completed

An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder (COMPASS)

Depressive Disorder, Major

United States, Russian Federation, Germany, Estonia, Mexico, Korea, Republic of, Chile, South Africa
Servier Russia

Completed

Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease (EQUALISER)

Hemorrhoids

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Direct and Cross Effects of Adaptation to Systemic Hyperthermia: Impact on Quality of Life, Neurohormonal and Psychophysiological Human Status

Quality of Life | Metabolic Disturbance | Exercise Tolerance | Hypoxia, Altitude

Russian Federation
I.M. Sechenov First Moscow State Medical University

Enrolling by invitation

Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications

COVID-19 | Quality of Life | Oxygen Consumption | Diastolic Dysfunction | Endothelial Function | Exercise Tolerance

Russian Federation
GlaxoSmithKline

Completed

Major Depressive Disorder In The Elderly

Depressive Disorder, Major

Belgium, Australia, Russian Federation, Netherlands, Norway, Finland
I.M. Sechenov First Moscow State Medical University

Completed

Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.

Metabolic Syndrome | Vascular Stiffness | Liver Fibroses | Trimethylamine N-oxyde | Toll-like Receptors

Russian Federation
Abbott
Manipal Acunova Ltd.

Completed

Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder (FRIENDS)

Depression

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.

COVID-19 | Quality of Life | Hypertension | Arrhythmia | Chronic Heart Failure | Endothelial Dysfunction | Conduct Disorder | Oxygen Consumption | Diastolic Dysfunction | Chronic Coronary Syndrome | Exercise Tolerance

Russian Federation
Immanuel Kant Baltic Federal University

Recruiting

Factors Influencing the Results of Treatment in Patients With Hernias of Various Localizations

Chronic Pain | Inguinal Hernia | Ventral Hernia | Umbilical Hernia | Femoral Hernia | Acute Post Operative Pain | Recrrence Rate

Russian Federation
Pfizer

Completed

A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Chile, United States, Estonia, Russian Federation
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study of Patients With Major Depressive Disorder and Residual Apathy

Major Depressive Disorder

Mexico, Russian Federation, Australia, Taiwan, Canada
Pfizer

Terminated

Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder

Depressive Disorder, Major

United States, Former Serbia and Montenegro, Russian Federation
Janssen Research & Development, LLC

Completed

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Major Depressive Disorder

Ukraine, Bulgaria, Romania, Russian Federation, Hungary, Moldova, Republic of
GlaxoSmithKline

Completed

Clinical Study to Test a New Drug to Treat Major Depression (PKI113009)

Depressive Disorder, Major

Bulgaria, United States, Germany, Russian Federation, Estonia
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Slovakia, Poland, Hungary, Japan, Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Not yet recruiting

Comparison of the Biomechanical Properties of the Wall of an Aneurysmal-altered Abdominal Aorta According to the Results of in Vivo Ultrasound and an Associated Study of Strength Characteristics in Vitro

the Strength Properties of the Aorta in Vivo | the Strength Properties of the Aorta in Vitro | Regression Model of Aortic Strength Properties in Vitro and in Vitro

Russian Federation
Voronezh Regional Clinical Consultative and Diagnostic...
Charles University, Czech Republic; Voronezh State Medical University named...

Completed

Myocardial Injury and Quality of Life After COVID-19

COVID-19 | Myocardial Injury | Myocarditis Post Infection

Russian Federation
Institut de Recherches Internationales Servier
ADIR Association

Completed

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Major Depressive Disorder

Bulgaria, Czechia, Finland, Hungary, Russian Federation, Slovakia, Ukraine
Intra-Cellular Therapies, Inc.

Completed

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Bipolar Depression | Major Depressive Disorder

United States, Bulgaria, Russian Federation, Serbia, Ukraine
Sunovion

Completed

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

Depressive Episode | Bipolar 1 Depression

Japan, Serbia, United States, Poland, Russian Federation, Bulgaria, Slovakia, Ukraine

Clinical Trials on Late-life Depression in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations